Allergology Xagena

Xagena Mappa
Medical Meeting
Xagena Salute

Search results for "Oralair"

The FDA ( Food and Drug Administration ) has approved Oralair, the first immunotherapy tablet to be available in the U.S. for the treatment of grass pollen-induced allergic rhinitis with or without co ...

Seasonal allergic rhinoconjunctivitis affects millions of persons. The efficacy of allergen sublingual immunotherapy ( SLIT ) was demonstrated in previous short-term studies. The aim of the study w ...